Ann: Q&A With Company CEO, Dr Alex Andrews, page-2

Good update, a lot of newsflow coming.

The Prednisone phase 2 is new news.

Good to see first confirmation of ASD timeline for efficacy data (this will be out of NTI's control to a degree as he overseeing Dr (name escapes me presently) will be leading this.

Monash is all but confirmed as the Phase 3 trial location. They wouldn't commit if they didn't like what they have seen from the phase 2.

Only thing missing in this is what other combinations are being reviewed in the clinic, and other pre-clinical investigations etc...